Atlas Trials

Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Clinical trial NCT04646928 · UNKNOWN

Trial details

NCT number
NCT04646928
Sponsor
CHA University
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis B
Start date
2017-03-17
Primary completion
2022-05-28
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.